The acquisition enables IntegenX to include SV Corp’s products and intellectual property assets to expand its consumables offering and to accelerate the commercialization of its RapidHIT 200 human DNA identification system.

IntegenX chief executive officer Stevan Jovanovich said, "The SV Corp acquisition brings to IntegenX proprietary products and a proven and protected IP estate containing key technical know-how in capillary electrophoresis, separation, sample preparation, and separation matrix."

The IntegenX RapidHIT 200 automates and accelerates the process of producing standardized DNA profiles from mouth swabs and other human samples in less than 90 minutes.